Vulnerability Description
Cross-site scripting (XSS) vulnerability in IBM Maximo Asset Management 7.1 through 7.1.1.8, and Maximo Asset Management 7.1 through 7.1.1.8 and 7.2 for Tivoli IT Asset Management for IT and certain other products, allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors, a different vulnerability than CVE-2015-0104, CVE-2015-0107, and CVE-2015-0109.
CVSS Score
MEDIUM
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Ibm | Change And Configuration Management Database | 7.1 |
| Ibm | Maximo Asset Management | 7.1 |
| Ibm | Maximo Asset Management Essentials | 7.1 |
| Ibm | Maximo For Government | 7.1 |
| Ibm | Maximo For Life Sciences | 7.1 |
| Ibm | Maximo For Nuclear Power | 7.1 |
| Ibm | Maximo For Oil And Gas | 7.1 |
| Ibm | Maximo For Transportation | 7.1 |
| Ibm | Maximo For Utilities | 7.1 |
| Ibm | Tivoli Asset Management For It | 7.1 |
| Ibm | Tivoli Service Request Manager | 7.1 |
Related Weaknesses (CWE)
References
- http://www-01.ibm.com/support/docview.wss?uid=swg21694974Vendor Advisory
- https://exchange.xforce.ibmcloud.com/vulnerabilities/99605
- http://www-01.ibm.com/support/docview.wss?uid=swg21694974Vendor Advisory
- https://exchange.xforce.ibmcloud.com/vulnerabilities/99605
FAQ
What is CVE-2015-0108?
CVE-2015-0108 is a vulnerability with a CVSS score of 4.3 (MEDIUM). Cross-site scripting (XSS) vulnerability in IBM Maximo Asset Management 7.1 through 7.1.1.8, and Maximo Asset Management 7.1 through 7.1.1.8 and 7.2 for Tivoli IT Asset Management for IT and certain o...
How severe is CVE-2015-0108?
CVE-2015-0108 has been rated MEDIUM with a CVSS base score of 4.3/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2015-0108?
Check the references section above for vendor advisories and patch information. Affected products include: Ibm Change And Configuration Management Database, Ibm Maximo Asset Management, Ibm Maximo Asset Management Essentials, Ibm Maximo For Government, Ibm Maximo For Life Sciences.